First Time Loading...
Z

Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267

Watchlist Manager
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Watchlist
Price: 8.33 CNY 2.08% Market Closed
Updated: May 6, 2024

Zhejiang Hisun Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Hisun Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Revenue
¥12B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
4%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue?
Revenue
12B CNY

Based on the financial report for Sep 30, 2023, Zhejiang Hisun Pharmaceutical Co Ltd's Revenue amounts to 12B CNY.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
4%

Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Zhejiang Hisun Pharmaceutical Co Ltd have been 3% over the past three years , 3% over the past five years , and 4% over the past ten years .